JNJ

COVID vaccine boosts J&J pharma sales in Q3
Medical Marketing and Media
Tue, 10/18/22 - 10:53 am
JNJ
COVID-19
vaccines
earnings
J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules
Fierce Pharma
Thu, 10/13/22 - 11:50 pm
i20 Therapeutics
Sanofi
JNJ
large molecule drugs
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
GSK
RSV
vaccines
clinical trials
Pfizer
JNJ
Moderna Therapeutics
RSVPreF3
BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica
Fierce Pharma
Wed, 10/12/22 - 11:00 am
BeiGene
AbbVie
JNJ
Imbruvica
blood cancers
Brukinsa
Biogen Looks at Former J&J Exec as Potential CEO Candidate
BioSpace
Mon, 10/10/22 - 07:00 pm
Biogen
Pharma CEOs
JNJ
Mathai Mammen
Janssen Touts Positive Mid-Late Stage Data From Two Ulcerative Colitis Trials
BioSpace
Mon, 10/10/22 - 10:52 am
JNJ
Janssen
ulcerative colitis
guselkumab
golimumab
After $100M deal, J&J links gene therapy to improved vision in early-phase trial
Fierce Biotech
Mon, 10/3/22 - 10:11 am
JNJ
gene therapy
clinical trials
retinal disease
MeiraGTx
X-linked retinitis pigmentosa
Go or no go? GSK takes its turn with a novel anemia class
EP Vantage
Fri, 09/30/22 - 10:52 am
FDA
GSK
Amicus Therapeutics
AstraZeneca
Novartis
Supernus
JNJ
Ipsen
Y-mAbs Therapeutics
Johnson & Johnson taps Scottish inspiration in branding its consumer spinoff
Fierce Pharma
Wed, 09/28/22 - 11:05 am
JNJ
branding
Kenvue
consumer health
spinoffs
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Takeda
JNJ
Novartis
ADHD
MHRA
Concerta XL
Ritalin XL
Equasym XL
Johnson & Johnson defends bankruptcy play in appeals court, but plaintiffs call it a 'bad faith' move
Fierce Pharma
Tue, 09/20/22 - 08:33 pm
JNJ
legal
bankruptcy
J&J opens new research hub near San Francisco
BioPharma Dive
Tue, 09/20/22 - 08:32 pm
JNJ
San Francisco
biotech hubs
R&D
Why Novavax and Johnson & Johnson Stocks Slipped Monday
Motley Fool
Mon, 09/19/22 - 10:00 pm
JNJ
Novavax
vaccines
Joe Biden
COVID-19
J&J settles gender discrimination and retaliation allegations involving former CEO and R&D head
Endpoints
Sun, 09/18/22 - 10:37 pm
JNJ
legal
gender discrimination
Alex Gorsky
retaliation
J&J expands in Ireland with a $100M+ investment for contact lens manufacturing site
Endpoints
Sun, 09/18/22 - 10:20 pm
JNJ
JNJ Vision
Ireland
contact lens
Former J&J executive settles with company in workplace discrimination lawsuit
Fierce Pharma
Thu, 09/8/22 - 04:27 pm
JNJ
legal
gender discrimination
J&J's Biosense Launches New Mapping Catheter
Medical Devices and Diagnostics Industry
Wed, 09/7/22 - 10:20 am
devices
Medtech
JNJ
Biosense Webster
cardiac mapping
cardiac arrhythmias
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
Janssen reports Phase II data for Darzalex-RVd to treat multiple myeloma
Clinical Trials Arena
Mon, 08/29/22 - 10:32 am
JNJ
Janssen
clinical trials
Darzalex
Revlimid
Velcade
Multiple Myeloma
BMS, J&J's secondary stroke med falls short in phase 2 but companies see enough potential to push forward
Fierce Biotech
Sun, 08/28/22 - 10:15 pm
JNJ
Bristol Myers Squibb
milvexian
secondary stroke
clinical trials

Pages